Natera is a diagnostics company. Co. engages in the discovery, development and commercialization of genetic testing services. Co.'s product offerings include: Panorama Non-Invasive Prenatal Test, which screens for chromosomal abnormalities of a fetus typically with a blood draw from the mother; Vistara, a single-gene mutations screening test performed to identify single-gene disorders; Horizon Carrier Screening, which determines carrier status for a number of severe genetic diseases that could be passed on to the carrier's children; and Spectrum, which analyzes chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle to select embryos for a pregnancy.
